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Abstract 
Introduction: The fetal malformations are sometimes consequences of certain diseases that a pregnant woman can 
submit, and can increase the risks in pregnancy and cause problems not only for the fetus as also for the pregnant. 
Aim: To determine the impact of chronic diseases in the development of the fetus, also evaluating their maternal 
complications. 
Methodology: This study refers to a literature review of studies published in the databases Web of Science and 
PubMed Search. For this research were selected a total of 27 articles, reports and books. This review was carried out 
from September to December 2015.  
Results: Asthma is a chronic disease may present variations as to its severity, however, the physician should always 
be attentive to functional and clinical parameters during pregnancy. In relation to the Arterial Hypertension, this is 
considered one of the most detrimental effects to the maternal, fetal and neonatal. 
Conclusion: Chronic diseases, in particular asthma and arterial hypertension, reveal a great impact during 
pregnancy, causing complications at the fetal and maternal level. 
Keywords: Arterial hypertension in pregnancy; Asthma in pregnancy; Diseases in pregnancy; Fetal malformations; 
Maternal complications 
 
Introduction 
          The fetal malformations are sometimes 
consequences of certain diseases that a pregnant 
woman can submit, and can cause a high risk pregnancy 
and cause problems not only for the fetus as also for the 
pregnant [1]. 
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     One of the chronic pathologies which may 
compromise the fetal well-being, developing maternal 
complications is Asthma. This disease is characterized 
by continuous or periodic symptoms of 
bronchoconstriction, including dyspnea, wheezing, 
sensation of chest oppression and cough [1].  
 
     The asthma in pregnancy is a pathology seen as a 
factor of elevated risk for both the expectant mother 
and the unborn child. According to the types and 
frequency of symptoms revealed by the patient, is 
classified as intermittent, mild persistent, moderate or 
severe [1]. Placing of part this pathology presented, 
there is a chronic disease, which is considered that 
constitutes a risk to the health of the pregnant woman 
and the fetus, designated Arterial Hypertension (AH) 
[2]. 
 
     The arterial hypertension (AH) disease during 
pregnancy, encompasses the induced hypertension, 
includes also the gestational hypertension 
(hypertension in proteinuria), pre-eclampsia (with 
proteinuria and eclampsia (pre-eclampsia with 
seizures) [2]. According to the degree of severity, 
arterial hypertension is seen as a risk factor, including 
certain obstetrical antecedents, individual 
characteristics, adverse socio-economic conditions and 
clinical occurrences, according to the Ministry of Health 
[3]. This disease is entirely responsible for high rates of 
morbidity and maternal and perinatal mortality, 
considered one of the main public health problems [4]. 
 
     The objective of this review is to know the impat of 
chronic diseases, such asthma and arterial 
hypertension, in the development of the fetus, and also 
evaluating their maternal complications. 
 
Materials and Methods 
     The present Mini Review consists of a literature 
review, based on search of articles in Web of Science 
and PubMed Search engines, in which the following 
keywords were used: Arterial hypertension in 
pregnancy; Asthma in pregnancy; Diseases in 
pregnancy; Fetal malformations; Maternal 
complications. Additionally, in order to increase the 
search results, were also included in this review 
websites of official entities and books linked to health. 
The inclusion criteria used were scientific articles, 
reports and books related to the theme, that had to do 
with the descriptors, in Portuguese or English language. 
After the initial search, were selected two diseases: 
asthma and arterial hypertension in pregnancy. Were 
included a total of 27 articles, reports and books. This 
review was carried out from September to December 
2015. 
Results 
     The World Health Organization (WHO) considers 
such as low birth weight, newborns weighing less than 
2500g, irrespective of gestational age and defines a 
premature birth, those whose birth occurs before 
completing the 37 weeks of gestation [5]. 
 
     The newborns should be compared with a similar 
population, taking as a basis the racial factors, ethnicity 
and fish stocks [6]. The perinatal gestational age can be 
determined by the method proposed by Capurro et al. in 
1977 [7], which evaluates the physical and neurological 
characteristics or the combination of both, very used in 
many maternities.  
 
Asthma in Pregnancy 
     Asthma is a disease of course mutable may present 
variations as to its severity, however, the physician 
should always be attentive to functional and clinical 
parameters [1].  
 
     In countries such as Canada, pregnant women that 
are diagnosed by asthma represent approximately 
0.43% [8]. While, that in countries such as the United 
States, may reach 8.4% [9]. 
 
     According to a study published in 1992, it was 
considered that the fetal distress was an indication for 
cesarean section in 25% of asthma cases that analyzed 
[10]. 
 
     As regards the pregnant women badly controlled in 
relation to asthma, there is a significant increase in the 
risk of complications at the level of the fetus, such as: 
low birth weight [11], pre-eclampsia/ eclampsia 
(runaway of arterial pressure) [12,13], the higher 
proportion of cesarean [14], prematurity [15,16] 
Perinatal morbidity and greater [17]. 
 
     In the case of pregnant woman presenting with 
controlled asthma more than 3 weeks, the medication 
should be reduced, but if the disease is partially 
controlled, not controlled or with worsening, the 
increase of the drug should be considered [1].  
 
     Pharmacological treatment of asthma does not entail 
adverse effects both in pregnant women as in the fetus, 
being benefited the binomial maternal fetal disease 
control [15]. 
 
     This treatment is mainly based on inhaled 
corticosteroids, and in casdos worsening of the clinical 
picture, the doses of this drug are adjusted, being 
possible to log an association of medications such as 
beta agonists, long-term and oral systemic 
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corticosteroids, for greater control of the clinical picture 
[18]. 
 
     According Lime et al. [19], the discontinuation of the 
treatment during pregnancy can contribute to the 
worsening of the breastfeeding, in which 25.8% of the 
professionals of the study were diminishing or 
interrupted prior medications, even in asthmatic crisis. 
 
     Schatz et al. [20] carried out a study that 52% of 
patients with severe asthma present exacerbation of the 
disease during pregnancy, there is a high number of 
pregnant women hospitalized. 
 
     There are certain factors that may lead to the 
worsening of this disease, such as the interruption of 
the use of medication, allergic reactions, stress and 
infection in the respiratory tract [19]. 
 
Arterial Hypertension in Pregnancy 
     In relation to the arterial hypertension, the 
repercussions more frequently associated with this 
disease in pregnancy are: the restriction of intra-uterine 
growth, low birth weight and prematurity [21].  
 
     An early diagnosis of the HA with a proper 
intervention at an opportune moment, the higher are 
the chances of a pregnancy without maternal 
complications and worsening of the health of the 
conceptus [21]. 
 
     The prematurity of the newborn is a very frequent 
complication of hypertensive disease, either due to the 
spontaneous labor or by obstetric conduct of 
interruption of pregnancy, a compromised maternal-
fetal [22]. 
 
     For an evaluation of the fetal growth in the 
intervention of this chronic disease, was stipulated a 
method currently known: New Ballard Method, whose 
result varies from 10 (corresponding to a gestational 
age of 20 weeks) to 50 (corresponding to 44 weeks of 
gestational age). This is a more accurate if the 
assessment is performed in the first 12 hours of life 
[23]. 
 
     The changes in fetal growth can be assessed by 
anthropometric measurements, such as, birth weight 
and gestational age. These variables help to define the 
intra-uterine growth curves, thus characterizing the 
newborn (NB) [24]. 
 
Discussion and Conclusion 
     The mechanism by which occurs reduction of fetal 
growth is not fully established, because the placental 
physiology seems to be modified in pregnancy 
complicated by maternal asthma by less enzyme activity 
of 11-beta-hydroxysteroid dehydrogenase type 2 in 
pregnancies with female fetuses [25]. This enzyme 
exercises a protective effect in the fetus, face to excess 
maternal glucocorticoids and influences the fetal 
growth [26]. 
 
     As regards the measures treatment in relation to 
asthma, are based on complementary oxygenation, so 
that the saturation remains above 95%, beta agonist of 
short duration and corticosteroids, prevention and 
correction of hypoxemia or reduction of hypercapnia 
[27]. 
 
     The care in the delivery of asthmatic patients should 
be cautious, even in the absence of disease worsening, 
and the continuous use of medications to control the 
disease should not be postponed or withdrawn due to 
labor [25]. 
 
     In relation to the arterial hypertension, the assistance 
and the concern in this disease also plays an extremely 
important role in the prevention of morbidity and 
maternal and perinatal mortality, since hypertension in 
pregnancy still cannot be avoided, while, maternal 
death in the majority of the times can be prevented [2]. 
With this review of the literature, it can be concluded 
that the maternal diseases, in particular Asthma and 
Arterial hypertension, reveal a great impact during 
pregnancy, causing complications the fetal and maternal 
level. 
 
     In short, every care must be extremely rendered in 
pregnant women that have some diseases, identified in 
this review and others, since it is necessary a high 
attention because of the consequences they entail both 
for the fetus as for maternal health, by putting it at risk 
of life. 
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